AO-OCT Comes into Focus

NISHANT MOHAN AND CICELY RATHMELL, WASATCH PHOTONICS

Adaptive optics (AO) technology is often used to correct for wavefront distortions imparted when light travels through complex optical systems, enhancing image resolution and facilitating diffraction-limited optics. It has played a particularly prominent role in ophthalmic imaging, where retinal tissue imaging is limited by inherent aberrations in the eye.

OCT
 

Given the widespread adoption of OCT in clinical diagnostics over the last 20 years, these two techniques should be natural partners. But because of technological limitations on both sides, practical applications of AO-OCT have been difficult to implement.

Improved imaging

AO refers to a family of techniques used for correcting distortions or aberrations in a light wave — aberrations that can occur whenever light passes through a translucent yet optically distorting medium such as the atmosphere or the human eye. Though originally developed to overcome the limitations of astronomical imaging through the earth’s atmosphere, AO has facilitated the resolution of many key retinal structures in the living eye since it was first used to observe cone photoreceptors more than 20 years ago1.

Most ophthalmic imaging techniques use the focusing power of the human eye itself to generate an image of the retina at the back of the eye, so their resolution is limited by diffraction because of the finite size of the eye’s pupil and ocular aberrations. AO mitigates this issue by compensating the initial wavefront for the aberrations experienced when working with a dilated pupil, which provides much better focusing and facilitates image resolution at the cellular level (Figure 1). The ability to visualize cells, organelles, and other microscopic structures, both in vivo and noninvasively, makes AO-based imaging invaluable for medical and scientific applications.

Figure 1. AO uses wavefront compensation to correct for naturally occurring aberrations in the eye, which improves the quality of focus for retinal imaging. Courtesy of Wasatch Photonics.

It has been successfully combined with several ophthalmic imaging techniques along with OCT, including fundus imaging and scanning laser ophthalmoscopy. Of these, OCT is the fastest-growing ophthalmic imaging technology, providing considerably more information about retinal layer structure. This technique has gained clinical importance because of its important role in managing critical retinal disorders such as age-related macular degeneration (AMD) and glaucoma.

While OCT can provide images at the tissue level in the axial dimension, its transverse resolution is limited by aberrations in the eye; therefore, it cannot be used for imaging at the cellular level without the aid of AO. Combining the two creates a unique and powerful tool capable of 3D cellular imaging, as shown in Figure 2. A wavefront sensor in the detection path is used to measure the wavefront aberration, and a wavefront compensator, such as a deformable mirror, then corrects the aberration in real time.

Figure 2. AO can be integrated into a typical ophthalmic OCT system via the addition of a deformable mirror for wavefront control and a wavefront sensor for active feedback, thus compensating for optical aberrations within the eye. Courtesy of Wasatch Photonics.

Early challenges

Early works in the field of AO-OCT combined adaptive optics with the time-domain variant of OCT. While good at a proof-of-concept level, the slow speed of time-domain OCT limited the application of AO to research use2,3. The development of Fourier domain OCT increased the speed of OCT imaging by orders of magnitude, enabling Zawadzki and colleagues in 20054 to show the combination of AO with Fourier domain OCT for 3D imaging. The technique clearly demonstrated increased sensitivity. However, the OCT acquisition rate was still not fast enough to overcome the motion artefacts that hamper in vivo volumetric cellular-level imaging.

It became clear that the success of AO-OCT in ophthalmology would require a delicate balancing act between all of the parameters of importance, including imaging speed, sensitivity, field of view, and cost. Visualization of microscopic structures within the retina (Figure 3) requires the acquisition of a 3D volume within a very short time frame. To obtain useful medical and biological information, the acquisition must also overcome the so-called keyhole problem, in which field of view limits the retinal patch sampled, providing too little information on global retinal disease to be useful.

Figure 3. Layers of the human retina, as defined by various functional cells. ILM: inner limiting membrane. NFL: nerve fiber layer; GCL: ganglion cell layer; IPL: inner plexiform layer; INL: inner nuclear layer; OPL: outer plexiform layer; ONL: outer nuclear layer; PL: photoreceptor layer; RPE: retinal pigment epithelium. Courtesy of Wasatch Photonics.

Herein lies the conundrum: Imaging at higher speeds results in fewer photons returned from the retina unless source power is increased proportionately. The delicate structures of the eye can only be exposed to a limited amount of optical power, however, and therefore higher speed has traditionally been achieved only at the expense of imaging sensitivity. The final challenge lies in the inherent expense of AO-based systems. Wavefront compensators, wavefront sensors, and high-speed OCT systems can be costly and complex components, impeding the commercialization of AO-OCT.

Increasing imaging speeds

Several attempts have been made to increase OCT imaging speeds for wide field, high-resolution imaging of the human retina. Kocaoglu and colleagues5 demonstrated 1-MHz spectral-domain OCT (SD-OCT) by multiplexing four OCT spectrometers to overcome the limited line rate supported at that time by OCT cameras. Swept-source OCT has also been explored as a natural choice for high-speed imaging solutions. Fourier domain mode-locked (FDML) lasers, a type of swept source, have achieved rates exceeding 1 MHz for retinal imaging.

The longer wavelength of 1050 nm used by swept-source OCT is considered ideal for deeper structures such as choroidal vessels and the optic nerve head region. However, these systems have both lower axial resolution and a larger diffraction-limited focus. In addition, high-speed, swept-source systems can be expensive. Given the already high cost of AO elements, any additional cost in OCT implementation is less than ideal for wide-scale use of AO-OCT.

Fortunately, advancements in SD-OCT technology look to spur AO-OCT toward wider acceptance. Recently introduced ultrahigh-speed commercial OCT spectrometers operating at 800-nm nominal wavelength have demonstrated the ability to provide rapid 3D tissue imaging while maintaining the superior resolution associated with shorter wavelengths using a single spectrometer system.

These benefits have been demonstrated in recent work by Zhuolin Liu and Daniel X. Hammer at the FDA, in collaboration with Johnny Tam at the National Eye Institute of the National Institutes of Health, and Dr. Osamah Saeedi, a clinical ophthalmologist at the University of Maryland6. Using a multimodal AO system that combines it with scanning laser ophthalmoscopy and ultrafast SD-OCT, they were able to perform cellular-level OCT imaging across the entire retinal depth at near-video scan rates. The AO-OCT transverse confocal image resolution of 1.8 µm and axial resolution of 3.7 µm proved sufficient to extract clear en face images showing microglia, nerve fiber bundles, retinal ganglion cells (RGC) and axons, capillaries in the inner retina and foveal cones, peripheral rods, and retinal pigment epithelial (RPE) cells in the outer retina (Figure 4).

Figure 4. Detailed 3D imaging of retinal cellular structures using a multimodal AO-OCT system utilizing a Wasatch Photonics Cobra-S 800-nm spectrometer. AO-OCT volume of the retina (a), a single AO-OCT B-scan (b), starlike microglial cells speckling the inner limiting membrane (c), nerve fiber layer showing nerve fiber bundles (d), ganglion cell layer showing a mosaic of somas (e), a composite image overlaying multiple colorized layer images (f), capillaries spanning the IPL-INL and INL-OPL boundaries (g, h), photoreceptor layer (i), retinal pigment epithelium (j). Courtesy of Zhuolin Liu and Daniel X. Hammer.

High-speed AO-OCT imaging proved particularly well suited to resolving more weakly scattering RGCs in the inner retina (retinal ganglion cells) and RPEs in the outer retina (the pigmented cell layer that nourishes retinal photoreceptor cells), even resolving the outer segment tip of the rod and the epithelium layers of the retinal pigment, which are often not separated in conventional OCT imaging. As a whole, this multimodal approach offers a unified system for the study of retinal structure and physiology that could aid in the development of new treatments for highly prevalent eye diseases such as glaucoma and AMD.

Next steps for development

The success of AO-OCT depends on more than just advancements in imaging speed. Precise wavefront control requires a deformable mirror, spatial light modulator, or MEMS-based device. The deformable mirrors that are popular in ophthalmic imaging act to control the incident wavefront by reshaping a reflecting membrane using a discrete set of magnetic actuators. Nanometer-level control and correction of higher-order aberrations requires many actuators, with stringent requirements on precision and stability.

As developments in deformable mirror technology promise to reduce the cost, size, and complexity of these devices, AO-OCT will improve imaging for a large portion of the clinical population and become more widely accepted. In fact, one applications-minded approach involves next-generation deformable mirrors that correct only critical lower-order aberrations instead of the much larger range of aberrations currently targeted. This has the potential to yield the same image quality as current AO-OCT technology at much lower cost and complexity, particularly when combined with high-speed SD-OCT technology.

Another development heralds sensorless AO, which forgoes the wavefront sensor in favor of utilizing image quality to adjust the deformable mirror. Removing the requirement for a wavefront sensor reduces both the size and the cost of the instrument, although the need for computationally complex algorithms can limit the imaging bandwidth.

Yet another interesting technique promising cellular-level resolution is computational AO-OCT, which uses the phase information carried by OCT data to correct for optical aberrations at different depths7. While their hardware is much simpler, computational techniques yield limited signal-to-noise ratio and require extremely fast imaging to avoid corruption of phase information by sample motion.

The future of AO-OCT

With its ability to visualize cellular structure in 3D at near-video rates, AO-OCT promises to be invaluable for many scientific, biological, and clinical applications. It is one of the very few techniques that allow us to visualize the cellular structure and the function of complex organs completely unperturbed, and in one of the clinically most relevant areas of the body. The increased resolution provided by AO-OCT has been invaluable in understanding the origins of layers seen close to the outer retina. It is shedding light on the progression of diseases such as geographic atrophy (GA) to suggest drug targets for as-yet untreatable conditions.

AO in combination with OCT angiography allows visualization and quantification of changes in microvascular structures that are critical to understanding diabetic retinopathy. AO-OCT has also shown early promise for better understanding and early diagnosis of glaucoma by imaging nerve fiber bundles in the retina and the lamina cribrosa in the optic nerve; the recent demonstration of AO-OCT to resolve the ganglion cell mosaic may soon change our understanding of glaucoma8.

But as promising as this technique has been in resolving retinal cells in vivo, the real value of AO-OCT can only be demonstrated through large-scale clinical studies specific to different disease domains via widespread adoption of AO-OCT instrumentation by the clinical community. Fortunately, the development of cost-effective commercial SD-OCT imaging products with high speed and sensitivity, bolstered by innovation in AO components and methods, are making this technique more accessible than ever.

These advancements — along with persistent efforts from vision scientists, ophthalmologists, and entrepreneurs — are bringing us closer to reaching a self-sustaining cycle of technological innovations and applications served by AO-OCT. If the eye is the window to the soul, then AO-OCT has the potential to throw open its sash.

Meet the authors

Nishant Mohan is vice president of the OCT division at Wasatch Photonics. He has actively participated in the strategy, marketing, research, and development of OCT for more than a decade, beginning at Bausch & Lomb Inc. in Rochester, N.Y., and as a research fellow at Harvard Medical School; email: nmohan@wasatchphotonics.com.

Cicely Rathmell is vice president of marketing at Wasatch Photonics. She has worked in the industry for 20 years, including in telecommunications, biotech, optical components, and spectroscopy. She holds an M.Sc. in physics from McMaster University; email: marketing@wasatchphotonics.com.

References

1. J. Liang et al. (1997). Supernormal vision and high-resolution retinal imaging through adaptive optics. J Opt Soc Am A, Vol. 14, Issue 11, pp. 2884-2892.

2. D.T. Miller et al. (2003). Coherence gating and AO in the eye. P Soc Photo-Opt Ins, Vol. 4956, https://doi.org/10.1117/12.477633.

3. B. Hermann et al. (2004). Adaptive optics ultrahigh-resolution optical coherence tomography. Opt Lett, Vol. 29, Issue 18, pp. 2142-2144.

4. R.J. Zawadzki et al. (2005). Adaptive-optics optical coherence tomography for high-resolution and high-speed 3D retinal in vivo imaging. Opt Express, Vol. 13, Issue 21, pp. 8532-8546.

5. O.P. Kocaoglu et al. (2014). AO optical coherence tomography at 1 MHz. Biomed Opt Express, Vol. 5, Issue 12, pp. 4186-4200.

6. Z. Liu et al. (2018). Trans-retinal cellular imaging with multimodal adaptive optics. Biomed Opt Express, Vol. 9, Issue 9, pp. 4246-4262.

7. N.D. Shemonski et al. (2015). Computational high-resolution optical imaging of the living human retina. Nat Photonics, Vol. 9, Issue 7, p. 440.

8. Z. Liu et al. (2017). Imaging and quantifying ganglion cells and other transparent neurons in the living human retina. Proc Natl Acad Sci, Vol. 114, Issue 48.

Best Scientific公司简介

Best Scientific1993年成立于英国,在显微镜和视觉系统领域提供各种产品用于生命和材料科学。我们可以根据客户的要求定制参数,预算,应用以及时间框架等给他们推荐合适的产品。我们以合适的价格提供合适的产品。我们公司是一个全面的视觉系统集成商,如果有可能,最好将使用现有设备帮助你建立一个合适的系统。然而,我们也可以提供完整的视觉系统,有照明、照相机和光学系统来达到您的要求。

专业供应如下设备:

  • 显微镜以及配套配件
  • 机器视觉系统
  • 用于数字成像的显微镜照相机耦合器
  • 数码相机和相关的图像捕获软件
  • 相机镜头
  • 十字线发生器
  • 相关产品的支架和人体工学安装设备
  • 所有相关光学零件和附件
  • 定制和特殊设计的零件Best Scientific的科学人员在这些产品的操作上也有丰富的经验,并能够提供帮助我们客户实现目标的建议

艾克斯玛 (Optolita UAB或Eksma Optics)产品介绍

艾克斯玛 (Optolita UAB或Eksma Optics)是世界知名的激光光学制造商和分销商,目前提供如光学棱镜,激光反射镜,窗口片,激光和非线性晶体,BBO和DKDP普克尔斯盒,脉冲选择器和Q-开关器件,太赫兹和红外晶体,紫外和红外光学部件,光机组合部件,光学系统和DPSS激光模块等各种产品。同时,Eksma Optics还提供极其多样的标准产品服务,支持快速库存发货。艾克斯玛已获得了ISO 9001:2008认证,Eksma Optics将不断完善高质量的管理体系,并持续追求卓越的客户体验

           晶体             EKSMA OPTICS可从库存快速提供各种不同的非线性晶体系列:如BBO, LBO, KTP, KDP, DKDP, AGS, ZGP, GaSe 等。同时我们还根据客户需求提供各种定制化非线性晶体。激光晶体包括: Nd:YAG, Yb:KGW, Yb:KYW, Nd:KGW, Ti:Sapphire, Dy3+:PbGa2S4等。太赫兹晶体包含有机晶体:DAST, DSTMS, OH1和半导体晶体ZnTe, GaSe。另外还有用于受激拉曼散射的硝酸钡和非掺杂的钨酸钾钆晶体。另外还提供各种支架(开放性支架、定位支架等),晶体控温炉(温度控制器TC1, 温控炉CO1, CH3, CH4, CH7 and CO10),DKDP, BBO 普克尔斯盒,普克尔斯盒支架和普克尔斯盒驱动。 非线性晶体(Nonlinear Crystals) 三硼酸锂晶体(Lithium Triborate-LBO)
偏硼酸钡(Beta Barium Borate-BBO)
磷酸二氘钾(Potassium Dideuterium Phosphate-KDP·DKDP)
磷酸氧钛钾(Potassium Titanyl Phosphate-KTP)
砷酸钛氧钾(Potassium Titanyle Arsenate-KTA)
铌酸锂(Lithium Iodate)
红外非线性晶体(ZnGeP2  AgGaSe2 AgGaS2 GaSe)
超薄非线性晶体(BBO  LBO KDP LiIO3  AgGaS2  GaSe)
激光晶体(Laser Crystals) Nd:YAG掺钕钇铝石榴石(Neodymium Doped Yttrium Aluminium Garnet)
Yb:KGd(WO4)2晶体 掺镱钨酸钆钾晶体(Yb-Doped Potassium Gadolinium Tungstate)
Nd:KGW掺钕钨酸钆钾(Nd-Doped Potassium Gadolinium Tungstate)
Ti:Sapphire掺钛蓝宝石(Titanium Doped Sapphire)
Dy3+:PbGa2S4
太赫兹晶体(Terahertz Crystals) GaSe ZnTe半导体太赫兹晶体(Semiconductor Terahertz Crystals)
太赫兹有机晶体DSTMS,DAST,OH1
拉曼晶体(Raman Crystals) KGW Ba(NO3)2受激拉曼散射晶体(Crystals for Stimulated Raman Scattering)
被动调Q晶体(Passive Q-switching Crystals)
定位架(Positioners & Holders) 非线性晶体的环形支架(Ring Holders for Nonlinear Crystals)
定位安装(Positioning Mount)
动态定位安装(Kinematic Positioning Mount)
非线性晶体外壳(Positioning Mount For Nonlinear Crystal Housing)
晶体炉(Crystal Ovens) 烤箱温度控制器TC1 CO1(TEMPERATURE CONTROLLER TC1 WITH OVEN CO1)
CH3非线性晶体炉(OVEN for nonlinear crystals)
CH4非线性晶体炉(OVEN for nonlinear crystals)
CH7非线性晶体炉(OVEN for nonlinear crystals)
精密电阻加热器盒TC2和Co10系列烤炉(Precision Resistive Heater kit TC2 and CO10 series ovens)
Nd:YAG激光光学元器件                            Nd:YAG激光光学元器件包括反射镜,透镜套件,偏振光学件,激光和非线性晶体 Nd:YAG 激光反射镜(Nd:YAG LaserLine Mirrors) Nd:YAG激光分光镜                                                                                                    分光镜可将任意偏振态的激光光束平均分成互成90度的两束光。平均光强为:R=(Rs+Rp)/2 and T=(Ts+Tp)/2
Nd:YAG 激光分光镜包括:
– 材料BK7; 波长1064 nm, 尺寸ø12.7×3 mm or ø25.4×6 mm
– 材料 UVFS; 波长1064 nm, 尺寸ø12.7×3 mm or ø25.4×6 mm
– 材料BK7; 波长532 nm, 尺寸ø12.7×3 mm or ø25.4×6 mm
– 材料UVFS; 波长532 nm, 尺寸ø12.7×3 mm or ø25.4×6 mm
– 材料UVFS; 波长355 nm, 尺寸ø12.7×3 mm or ø25.4×6 mm
– 材料UVFS; 波长266 nm, 尺寸ø12.7×3 mm or ø25.4×6 mm
Nd:YAG激光后反射镜 激光后反射镜镀有介质膜,广泛用于脉冲或高功率连续Nd:YAG激光器基频应用中。
反射镜上的高反射率能达到R>99.8%,同时采用UVFS基片,典型尺寸为Ø 25.4x6mm
Nd:YAG激光输出耦合镜  激光输出耦合镜实际上是一个半(或部分)反射镜。一般来说,较低的透过率,损伤阈值也会较低,但较高的透过率,腔内效率也会较低。通常输出耦合镜的选择依然要以最大的输出功率为目标,即使有时会因为其他的设计原因,最后优化后的实际值可能更高些或更低些(如被动锁模激光器中需要考虑降低腔内密度,抑制调Q不稳定性的设计等)
Nd:YAG激光谐波分束器 期望振荡加强的波长反射率大于99.5%,而不需要的谐振波长透过率大于90%
0.5英寸或1英寸BK7或UVFS基底,表面面形优于λ/10;
后表面镀AR增透膜
Nd:YAG双波长激光反射线镜 双波长激光反射线镜有高质量的BK7或者熔融石英加工而成。反射镜的入射角度为45度,表面高度精抛,具有超低的散射及超高的损伤阈值,这种介质膜激光反射镜有效确保了Nd:YAG激光器输出近乎完美的光束质量
Nd:YAG激光线镜 当前我们有两种类型的基底材料供选择。所有的激光反射镜设计的入射角均为45度,表面高度精抛,具有超低的散射与超高的抗损伤阈值,这种介质膜激光反射镜有效确保了Nd:YAG激光器输出近乎完美的光束质量
Nd:YAG激光透镜套件 透镜套件包含4种基本的透镜类型。所有的透镜针对Nd:YAG激光基频和各级次谐波波长均镀有抗反射AR膜
NdYAG激光窗口片 窗口片针对Nd:YAG激光器基频和各级次倍频谐波波长镀有AR增透膜:1064nm,532nm,355nm,266nm
NdYAG激光晶体(Nd:YAG Laser Crystals)  Nd:YAG激光棒和各种倍频非线性晶体 倍频晶体 LBO晶体具有高损伤阈值,低光束偏移和优异的倍频效率。是高功率高重复频率Q-Switch和锁模激光器倍频的最佳选择
KTP晶体具有超高效率特别适合地平均功率和连续激光应用。该晶体对温度变化不敏感并能工作在极其锋利聚焦或高发散角激光光束环境
大孔径的DKDP晶体在高能量Q-Switch激光器中有广泛应用
普克尔斯盒 Nd:YAG激光晶体(标准激光棒) 提供各种标准尺寸的Nd:YAG激光棒,包括AR增透膜,适合高能量高功率的脉冲激光应用
KTP普克尔斯盒
BBO普克尔斯盒
KDP普克尔斯盒

欢迎来到尖丰光电!

        大家好!欢迎来到尖丰光电的blog!我们团队将竭诚为各位提供各种仪器设备及技术咨询!

      上海尖丰光电技术有限公司是专业从事光电领域内仪器设备代理与系统集成业务的综合性服务商,主要代理国内外知名品牌激光、光纤通信,光电子,光学仪器等光电产品的设计、引进、研发,技术咨询及销售。目前我们代理的国内外光电仪器,均为各自领域内的技术领先产品。

       我们的客户覆盖各著名高校、中国科学院所属各研究所、信息产业部各研究所、航空工业总公司各研究所、光电产业等不同领域。我们可以为用户提供国外原厂生产的各类标准产品。我们也愿意根据用户的具体要求,提供专业级光电实验室解决方案的设计。

       团队核心人员具有在行业内10年以上的激光光电子领域工作经验,保持对各应用领域新研究动向的了解,从而能够结合我们的经验和仪器设备的技术特点,按照广大用户的不同应用要求,提供准确、先进的各种仪器或系统解决方案。

我们核心竞争力在于:

  • 专业服务:扎实的理论基础、丰富科研实践经验和良好的服务品质,我们和众多知名高校、科研院所和公司有着良好的合作关系。我们不仅为您提供高质量的产品和优质的专业服务,更提供令您满意的解决方案。
  • 交货及时:高效快捷的进口以及代理流程,以丰富经验力争让用户在短的时间内收到订购的仪器
  • 敬业精神:我们通过与客户的充分沟通,尽可能满足客户的需求;我们不会因为订单大小而区别对待客户
  • 性价比高:我们会以优惠的价格为您提供符合您要求的产品

我们欢迎客户委托我们向国外厂商进口仪器,从而把客户从繁琐的进口手续中解放出来。